Digital Acceleration of Discovery Research

Leveraging Digital technologies to revolutionize R&D processes in the Life Sciences industry

The pharmaceutical industry has entered the digital era of drug development with the use of new age technologies like Artificial Intelligence, Machine Learning, Blockchain and Digital Process Automation.

Bio-pharmaceutical companies must now embrace innovation coupled with pioneering technology in order to manage and utilize the massive amount of data that is generated during the drug discovery process. The results will be shorter time-to-market and improved business metrics like revenue and profitability.

While these new-age technologies across the R&D process aim to simplify, streamline and accelerate the drug development process, there is still an imminent need for a holistic platform that brings together various people and IT applications into a process fabric and provide a unified view for better business execution.

Join technology thought leaders, industry analysts and leaders from top biopharmaceutical companies, as they discuss ‘The Digital Acceleration of Drug Discovery & Research’.

During this one hour session, we will discuss:

• Technology enabled opportunities in the Drug Discovery space
• Insights into how top Biopharmaceutical companies are making their organizations future-ready
• The roadmap to driving scientific & operational excellence to achieve data driven insights and decision making

Moderator:

Dr.P.Ratnakar, Global Practice Head - Lifesciences, Tech Mahindra

Panelists:

Raymond Ha, Senior Informatics Systems Analyst, Genentech

Natesh Parameswaran, Vice President & Global Head – Digital Process Solutions, Tech Mahindra

Jitesh Rohatgi, Global director and healthcare/life sciences principal, Pegasystems